Locus Bioscience
  • Platforms
  • Programs
  • Manufacturing
  • Careers
  • About Us
  • Newsroom
Contact
Media

News

67 Articles found
News Press Releases Locus Insights

Posts pagination

1 2 3 … 7 Next
  • September 10, 2024

    Crispr-Enhanced Viruses Are Being Deployed Against UTIs

    Learn More
  • September 9, 2024

    Phage Therapy’s Neglected Potential Is Finally Being Realized

    Learn More
  • February 1, 2024

    Antimicrobial Resistance: Multiple Threats, Multiple Responses

    Learn More
  • February 1, 2024

    Locus milestone unlocks more BARDA cash

    Learn More
  • January 26, 2024

    Locus Biosciences receives $23.9 million from BARDA for CRISPR-engineered therapy trial

    Learn More
  • January 26, 2024

    BARDA backs Locus phage therapy for resistant E coli

    Learn More
  • January 26, 2024

    Locus Biosciences Receives $23.9 Million Boost for Bacteriophage Therapy Advancement in UTI Treatment

    Learn More
  • January 26, 2024

    BARDA Funds Next Stage of CRISPR-Based Bacteriophage Therapy

    Learn More
  • October 16, 2023

    Phages and Synthetic Biology Team Up to Tackle Antimicrobial Resistance

    Learn More
  • October 13, 2023

    Dangerous ‘Superbugs’ Are on the Rise. What Can Stop Them?

    Learn More

Posts pagination

1 2 3 … 7 Next

Careers

We are on a mission to revolutionize the treatment of disease. We need intelligent, open, hard-working people who thrive in a fast-paced environment to join us on our quest.

Join Our Team

Media Inquiries


For all media inquiries, please contact
our public relations agency below

Contact Now
Locus Biosciences

Precision Medicines for Bacterial Infections
and Immunologic Diseases

Home

Platform

Programs

Manufacturing

Careers

About Us

Newsroom

Contact Us

Location

523 Davis Drive Suite 350
Morrisville NC 27560

Email

info@locus-bio.com

Linkedin

Linkedin

Twitter

Twitter

©Copyright 2025 Locus Biosciences, Inc. All rights reserved.

powered by wildfire